AII
BIO icon

AGF Investments Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

AGF Investments Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-372
Closed -$212K – 734
2021
Q1 		$212K Sell
372
-404
-52% -$239K ﹤0.01% 577
2020
Q4 		$452K Buy
776
+6
+0.8% +$3.42K ﹤0.01% 483
2020
Q3 		$397K Buy
770
+154
+25% +$78K ﹤0.01% 472
2020
Q2 		$278K Sell
616
-199
-24% -$87.8K ﹤0.01% 574
2020
Q1 		$286K Buy
+815
New +$300K ﹤0.01% 468

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AGF Investments Inc's BIO Position: Q2 2021 in Review

AGF Investments Inc sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 372 shares — an estimated $212K sold.

AGF Investments Inc first reported a position in BIO in Q1 2020 and held it in 5 quarters. The position peaked at $452K in Q4 2020. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • AGF Investments Inc reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
  • AGF Investments Inc sold 372 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $212K.
  • AGF Investments Inc first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and held it in 5 quarters.
  • AGF Investments Inc's Bio-Rad Laboratories Class A position peaked at $452K in Q4 2020.
  • 509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on AGF Investments Inc's 13F filing for Q2 2021, filed 10 Aug 2021.